Detalhe da pesquisa
1.
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes.
Cardiovasc Diabetol;
21(1): 21, 2022 02 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35130909
2.
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms.
Curr Atheroscler Rep;
24(6): 399-405, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35355214
3.
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
Diabetologia;
64(3): 668-680, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33409569
4.
VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly.
Arterioscler Thromb Vasc Biol;
40(3): 819-829, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32078365
5.
A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.
J Lipid Res;
61(7): 1128-1139, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32404332
6.
Stable Isotope Kinetic Study of ApoM (Apolipoprotein M).
Arterioscler Thromb Vasc Biol;
38(1): 255-261, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29146748
7.
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
Arterioscler Thromb Vasc Biol;
38(3): 592-598, 2018 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29284604
8.
Key aspects of PCSK9 inhibition beyond LDL lowering.
Curr Opin Lipidol;
29(6): 453-458, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30199407
9.
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.
J Lipid Res;
59(5): 892-900, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29540575
10.
PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate.
Clin Sci (Lond);
132(10): 1075-1083, 2018 05 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29724769
11.
Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia.
J Atheroscler Thromb;
30(3): 274-286, 2023 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35676030
12.
Effect of omega-3 fatty acid ethyl esters on postprandial arterial elasticity in patients with familial hypercholesterolemia.
Clin Nutr ESPEN;
55: 174-177, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37202042
13.
Lysosomal acid lipase deficiency: A rare inherited dyslipidemia but potential ubiquitous factor in the development of atherosclerosis and fatty liver disease.
Front Genet;
13: 1013266, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36204319
14.
Smooth Muscle Cell-Macrophage Interactions Leading to Foam Cell Formation in Atherosclerosis: Location, Location, Location.
Front Physiol;
13: 921597, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35795646
15.
Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity.
J Clin Med;
11(5)2022 Feb 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35268435
16.
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors.
Cardiovasc Res;
118(9): 2103-2111, 2022 07 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34314498
17.
Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.
Circ Genom Precis Med;
15(2): e003489, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35133173
18.
Macrophages in Atherosclerosis, First or Second Row Players?
Biomedicines;
9(9)2021 Sep 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34572399
19.
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function.
Atherosclerosis;
326: 47-55, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33933263
20.
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes.
Atherosclerosis;
293: 49-56, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31835041